Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# EPTC: We are one of the few centers in the world dedicated to phage therapy. It is part of the Eliava Institute of Bacteriophages, Microbiology and Virology, a research facility with broad experience in bacteriophage science and applications since 1923.

## Sitemaps
[XML Sitemap](https://eptc.ge/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [La terapia phagica, una grande opportunity, ora anche per i pazienti italiani](https://eptc.ge/la-terapia-phagica-una-grande-opportunity-ora-anche-per-i-pazienti-italiani/): Dopo i paesi europei e non solo, arriva finalmente la terapia phagica in Italia con la rappresentanza ufficiale Il Centro di terapia Fagica di Eliava. Questa terapia phagica in Italia offre una soluzione 100% naturale per i pazienti italiani.Dopo i paesi europei e non solo, arriva anche in Italia con la reppresentanza ufficiale Il Centro di terapia Fagica di Eliava, affiliato all'Istituto di Batteriofagia, Microbiologia e Virologia George Eliava (IBMV).
- [Attack of the bacteria eaters](https://eptc.ge/attack-of-the-bacteria-eaters/): In June 2018, Eva Maria Maicovski and her husband fly to Tbilisi, where they spend three weeks. They live in an apartment organized by the Eliava Center. Every day a chauffeur takes them and an interpreter to the institute, where Maicovski is examined and initially treated with a standardized phage preparation.
- [Could phage therapy help combat antimicrobial resistance?](https://eptc.ge/could-phage-therapy-help-combat-antimicrobial-resistance/): Antimicrobial Resistance killed over a million people in 2019. That figure is expected to rise to ten million by 2050. Antibiotics remain vital to modern medicine, but this hidden pandemic of drug-resistant superbugs is driving scientists to explore possible alternatives. One type of therapy in particular is attracting serious scientific interest: bacteriophages.
- [Western Firms Are Becoming Interested in a Soviet Medicine](https://eptc.ge/western-firms-are-becoming-interested-in-a-soviet-medicine/): Source: https://www.economist.com/science-and-technology/2023/05/03/western-firms-are-becoming-interested-in-a-soviet-medicine
- [How To Battle Superbugs With Viruses That “eat” Them](https://eptc.ge/how-to-battle-superbugs-with-viruses-that-eat-them/): Source: https://www.economist.com/leaders/2023/05/03/how-to-battle-superbugs-with-viruses-that-eat-them
- [Anil Leidet an Chronischen Lungeninfekten. Eine Längst Vergessen Geglaubte Therapie Gibt Ihm Neue Hoffnung](https://eptc.ge/anil-leidet-an-chronischen-lungeninfekten-eine-langst-vergessen-geglaubte-therapie-gibt-ihm-neue-hoffnung/): Antibiotika verlieren an Wirkung. Für Schwerkranke gibt es eine neue Hoffnung, die eigentlich alt ist: die Phagentherapie. Wer kann von den Viren, die keine Krankheiten verursachen, sondern Bakterien zerstören, profitieren?
- [Phage Therapy in Georgia](https://eptc.ge/phage-therapy-in-georgia/): Es ist „seine letzte Chance“, sagt Dieter Offermann. Der 60-Jährige fliegt nach Tiflis, Georgien, um sein Bein zu retten. Seit sieben Jahren kämpft er gegen Bakterien, die nach einer Knie-OP in die Wunde eingedrungen sind. Kein Antibiotikum hilft. Die Ärzte raten zur Amputation. Wird die Phagentherapie in Georgien sein Bein retten können?
- [Viruses That Could Save Millions of Lives](https://eptc.ge/viruses-that-could-save-millions-of-lives-copy/): It may seem strange after a pandemic that has killed millions and turned the world upside down, but viruses could save just as many lives.
- [Phenotypic and Genetic Characterization of Aeromonas Hydrophila](https://eptc.ge/phenotypic-and-genetic-characterization-of-aeromonas-hydrophila-phage-ahmtk13a-and-evaluation-of-its-therapeutic-potential-on-simulated-aeromonas-infection-in-danio-rerio/): Phage therapy can be an effective alternative to standard antimicrobial chemotherapy for control of Aeromonas hydrophila infections in aquaculture. Aeromonas hydrophila-specific phages AhMtk13a and AhMtk13b were studied for basic biological properties and genome characteristics. Phage AhMtk13a (Myovirus, 163,879 bp genome, 41.21% CG content) was selected based on broad lytic spectrum and physiologic parameters indicating its lytic nature. The therapeutic potential of phage AhMtk13a was evaluated in experimental studies in zebrafish challenged with A. hydrophila GW3-10 via intraperitoneal injection and passive immersion in aquaria water. In experimental series 1 with single introduction of AhMtk13a phage to aquaria water at phage–bacteria ratio 10:1, cumulative mortality 44% and 62% was registered in fish exposed to phage immediately and in 4 h after bacterial challenge, correspondingly, compared to 78% mortality in the group with no added phage. In experimental series 2 with triple application of AhMtk13a phage at ratio 100:1, the mortality comprised 15% in phage-treated group compared to the 55% in the control group. Aeromonas hydrophila GW3-10 was not detectable in aquaria water from day 9 but still present in fish at low concentration. AhMtk13a phage was maintained in fish and water throughout the experiment at the higher concentration in infected fish.
- [Phage Therapies for Superbug Infections Are Being Tested in Belgium](https://eptc.ge/phage-therapies-for-superbug-infections-are-being-tested-in-belgium/): Source: https://www.newscientist.com/article/2304997-phage-therapies-for-superbug-infections-are-being-tested-in-belgium/
- [Significance of lysogeny for the Metabolism of Desulfovibrio spp. Strains Isolated From Aquatic Environments of Georgia](https://eptc.ge/significance-of-lysogeny-for-the-metabolism-of-desulfovibrio-spp-strains-isolated-from-aquatic-environments-of-georgia/): Aims: Sulphate-reducing bacteria (SRB) are ecologically important group of anaerobic micro-organisms that can reduce sulphate to form hydrogen sulphide-a toxic gas causing iron corrosion on metal surfaces. In this work, SRB strains were isolated from aquatic environments in the country of Georgia to determine their lysogenicity and the role of temperate phages in host metabolism.
- [Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence](https://eptc.ge/phage-therapy-experience-at-the-eliava-phage-therapy-center-three-cases-of-bacterial-persistence/): In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy.  By looking at bacterial strains and personalized phages, we identified two distinct phage adaptation strategies that are employed by these pathogens. 
- [Investigation of Salmonella Phage–Bacteria Infection Profiles: Network Structure Reveals a Gradient of Target-Range from Generalist to Specialist Phage Clones in Nested Subsets](https://eptc.ge/investigation-of-salmonella-phage-bacteria-infection-profiles-network-structure-reveals-a-gradient-of-target-range-from-generalist-to-specialist-phage-clones-in-nested-subsets/): Bacteriophages that lyse Salmonella enterica are potential tools to target and control Salmonella infections. Investigating the host range of Salmonella phages is a key to understand their impact on bacterial ecology, coevolution and inform their use in intervention strategies. Virus–host infection networks have been used to characterize the “predator–prey” interactions between phages and bacteria and provide insights into host range and specificity. Here, we characterize the target-range and infection profiles of 13 Salmonella phage clones against a diverse set of 141 Salmonella strains. The environmental source and taxonomy contributed to the observed infection profiles, and genetically proximal phages shared similar infection profiles. Using in vitro infection data, we analyzed the structure of the Salmonella phage–bacteria infection network. The network has a non-random nested organization and weak modularity suggesting a gradient of target-range from generalist to specialist species with nested subsets, which are also observed within and across the different phage infection profile groups. Our results have implications for our understanding of the coevolutionary mechanisms shaping the ecological interactions between Salmonella phages and their bacterial hosts and can inform strategies for targeting Salmonella enterica with specific phage preparations.
- [Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments](https://eptc.ge/case-report-chronic-bacterial-prostatitis-treated-with-phage-therapy-after-multiple-failed-antibiotic-treatments/): Background: Chronic Bacterial Prostatitis (CBP) is an inflammatory condition caused by a persistent bacterial infection of the prostate gland and its surrounding areas in the male pelvic region. It is most common in men under 50 years of age. It is a long-lasting and debilitating condition that severely deteriorates the patient’s quality of life. Anatomical limitations and antimicrobial resistance limit the effectiveness of antibiotic treatment of CBP. Bacteriophage therapy is proposed as a promising alternative treatment of CBP and related infections. Bacteriophage therapy is the use of lytic bacterial viruses to treat bacterial infections. Many cases of CBP are complicated by infections caused by both nosocomial and community acquired multidrug resistant bacteria. Frequently encountered strains include Vancomycin resistant Enterococci, Extended Spectrum Beta Lactam resistant Escherichia coli, other gram-positive organisms such as Staphylococcus and Streptococcus, Enterobacteriaceae such as Klebsiella and Proteus, and Pseudomonas aeruginosa, among others.
- [Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma](https://eptc.ge/interactions-of-bacteriophages-and-bacteria-at-the-airway-mucosa-new-insights-into-the-pathophysiology-of-asthma/): The airway epithelium is the primary site where inhaled and resident microbiota interacts between themselves and the host, potentially playing an important role on allergic asthma development and pathophysiology. With the advent of culture independent molecular techniques and high throughput technologies, the complex composition and diversity of bacterial communities of the airways has been well-documented and the notion of the lungs' sterility definitively rejected. Recent studies indicate that the microbial composition of the asthmatic airways across the spectrum of disease severity, differ significantly compared with healthy individuals. In parallel, a growing body of evidence suggests that bacterial viruses (bacteriophages or simply phages), regulating bacterial populations, are present in almost every niche of the human body and can also interact directly with the eukaryotic cells. The triptych of airway epithelial cells, bacterial symbionts and resident phages should be considered as a functional and interdependent unit with direct implications on the respiratory and overall homeostasis. While the role of epithelial cells in asthma pathophysiology is well-established, the tripartite interactions between epithelial cells, bacteria and phages should be scrutinized, both to better understand asthma as a system disorder and to explore potential interventions.
- [Bacteriophage Therapy as a Potential Management Option for Surgical Wound Infections](https://eptc.ge/bacteriophage-therapy-as-a-potential-management-option-for-surgical-wound-infections/): To investigate the potential role of bacteriophages in the treatment of surgical infections, we conducted a retrospective analysis of four surgical patients who have sought treatment at the Eliava Phage Therapy Center, Tbilisi, Georgia. Two patients had chronic osteomyelitis, one presented with a diabetic foot ulcer, and the fourth patient had developed a severe infectious complication after skin grafting surgery. Patients were treated with different combinations of bacteriophage preparations, based on the sensitivity of the isolated bacterial strain toward commercially available bacteriophages. The treatment lasted on average for 1 month, and positive results were obtained in all four cases: the wounds have healed, the general health status of the patients has improved. No allergic or adverse reactions have been observed throughout the treatment.
- [Bacteriophages](https://eptc.ge/bacteriophages/): Even bacteria can get a virus! The viruses that infect bacteria are called bacteriophages, and certain bacteriophages have been studied in detail in the lab (making them some of the viruses we understand best).In this articles, we'll take a look at two different cycles that bacteriophages may use to infect their bacterial hosts:
- [Phage to Rescue](https://eptc.ge/phage-to-rescue/): Source: https://www.dailypioneer.com/2019/pioneer-health/phage-to-rescue.html?fbclid=IwAR2o13S1J3bRh5dHpwY2vynaqasvovyy9kJD-OR9absMfMa2mdO0rtEDIZU
- [The Perfect Predator? Inside the Tbilisi Clinic Pioneering a Radical Superbug Treatment](https://eptc.ge/the-perfect-predator-inside-the-tbilisi-clinic-pioneering-a-radical-superbug-treatment/): Source: https://www.telegraph.co.uk/global-health/science-and-disease/perfect-predator-inside-tbilisi-clinic-pioneering-radical-superbug/
- [Phages: Bacterial Eaters from Georgia as the Medicine of Tomorrow](https://eptc.ge/phages-bacterial-eaters-from-georgia-as-the-medicine-of-tomorrow/): Was tun, wenn Antibiotika nicht mehr wirken? Betroffene aus aller Welt zieht es nach Georgien, um sich dort mit Bakteriophagen behandeln zu lassen. Inzwischen ist die Phagentherapie auch in Belgien möglich.
- [Santé: Ces Pays Qui Pratiquent Encore la Phagothérapie](https://eptc.ge/sante-ces-pays-qui-pratiquent-encore-la-phagotherapie/): La phagothérapie, inventée il y a un siècle par un biologiste de l'Institut Pasteur, utilise des virus pour manger des bactéries. Avec les antibiotiques, les pays occidentaux se sont détournés de cette médecine, mais certains la pratiquent toujours, à l'image de la Géorgie.
- [Chronic Wound](https://eptc.ge/chronic-wound/): Patient Education: Chronic Wound
- [Could Viruses Help Fight Super-Bugs?](https://eptc.ge/could-viruses-help-fight-super-bugs/): We are slowly running out of ammunition to fight antibiotic resistant bacteria. Listener Peter wants to know whether a therapy that he’d heard about in the 1980s could be revived to help us where antibiotics falls short.CrowdScience travels to Georgia where “phages”, viruses that hunt and kill bacteria, have been used for nearly 100 years to treat illnesses ranging from a sore throat to cholera. Phages are fussy eaters – a specific phage will happily chew on one bug but ignore another. In Georgia, scientists have kept rare phages safe for decades and are constantly on the look-out for new ones. CrowdScience presenter Marnie Chesterton speaks to the scientists and doctors who are pioneering phage-therapy as well as overseas patients who have travelled thousands of miles in hope of finding a cure.
- [Diabetic Foot](https://eptc.ge/diabetic-foot/): Patient education: Diabetic foot
- [Prostatitis](https://eptc.ge/prostatitis/): Patient education: Prostatitis
- [Cystitis](https://eptc.ge/cystitis/): Patient education: Cystitis
- [History of EPTC](https://eptc.ge/history-of-eptc/): A century ago, the French-Canadian microbiologist Félix d’Herelle, recognized an “invisible microbe” that he proposed was a ‘bacteriophage’ virus with bacteria-devouring properties.
- [‘Broadband’ Networks of Viruses May Help Bacteria Evolve Faster](https://eptc.ge/broadband-networks-of-viruses-may-help-bacteria-evolve-faster/): Read More: "https://www.quantamagazine.org/broadband-networks-of-viruses-may-help-bacteria-evolve-faster-20181016/"
- [7 Facts About Bacteriophages](https://eptc.ge/7-facts-about-bacteriophages/): Bacteriophages are "bacteria eaters" in that they are viruses that infect and destroy bacteria. Sometimes called phages, these microscopic organisms are ubiquitous in nature. In addition to infecting bacteria, bacteriophages also infect other microscopic prokaryotes known as archaea. This infection is specific to a specific species of bacteria or archaea. A phage that infects E. coli for instance, will not infect anthrax bacteria. Since bacteriophages do not infect human cells, they have been used in medical therapies to treat bacterial diseases.
- [A Century-Old Cure May Help Ward Off Superbugs, The ‘Global Climate Change of Health’](https://eptc.ge/a-century-old-cure-may-help-ward-off-superbugs-the-global-climate-change-of-health/): Read More: https://www.thestar.com/news/world/2018/06/30/a-century-old-cure-may-help-ward-off-superbugs-the-global-climate-change-of-health.html
- [Cystic fibrosis (CF)](https://eptc.ge/cystic-fibrosis-cf/): Patient education: Cystic fibrosis (CF)
- [Irritable bowel syndrome](https://eptc.ge/irritable-bowel-syndrome/): Patient education: Irritable bowel syndrome
- [A credible alternative to antibiotics for treating drug-resistant infections](https://eptc.ge/credible-alternative-antibiotics-treating-drug-resistant-infections/): https://www.youtube.com/watch?v=lhPPJJZ6SUg
- [The Deadliest Being on Planet Earth – The Bacteriophage](https://eptc.ge/deadliest-planet-earth-bacteriophage/): Did you know that the bacteriophage deadliest being on our planet is actually a virus that saves human lives? While it holds the title of the world's most efficient killer of bacteria, its precision is what makes it a medical miracle. This video explores the fascinating nature of the bacteriophage deadliest being, showcasing its unique structure and life cycle. At the Eliava Center, we harness the power of the bacteriophage deadliest being to combat antibiotic-resistant infections. By understanding how the bacteriophage deadliest being operates, scientists can develop targeted therapies that surpass traditional medicine. Watch to discover why the bacteriophage deadliest being is the ultimate weapon against superbugs and a cornerstone of future healthcare..
- [FDA Clears Clinical Studies for New Bacteriophage Treatment for Crohn’s Disease](https://eptc.ge/fda-clears-clinical-studies-new-bacteriophage-treatment-crohns-disease/): We are one step closer to seeing a new kind of treatment to combat inflammatory bowel disease (IBD). On February 15, the U.S. Food and Drug Administration (FDA) gave its seal of approval to a new Phase 1/2 clinical trial in humans at Mount Sinai hospital in New York City to test a new bacteriophage treatment for Crohn’s disease.
- [Superbugs Are Nearly Impossible to Fight. This Last-Resort Medical Treatment Offers Hope](https://eptc.ge/superbugs-nearly-impossible-fight-last-resort-medical-treatment-offers-hope/): Every year in the U.S., at least 2 million Americans are diagnosed with an infection that doesn’t respond to antibiotics, and according to conservative estimates, 23,000 of them will die from their infections. The U.S. Centers for Disease Control and Prevention acknowledges that these figures are likely an underestimate: hospitals are not required by the federal government to report the number of superbugs they encounter, and death certificates rarely mention them directly (instead, complications from other ailments are often cited). Experts caution that the day is not far off when a paper cut or an ear infection turns lethal. Economists predict that by 2050, as many as 10 million people per year will die from drug-resistant infections.
- [Viruses discovered a century ago may be our best defense against a threat that could kill 10 million people a year by 2050](https://eptc.ge/viruses-discovered-century-ago-may-best-defense-threat-kill-10-million-people-year-2050/): Antibiotic resistance — the phenomenon in which bacteria stop responding to certain antibiotics — is a growing threat around the world.
- [Could gargling a virus that eats bacteria solve the SUPERBUG CRISIS?](https://eptc.ge/gargling-virus-eats-bacteria-solve-superbug-crisis/):  
- [Addressing superbug resistance with phage therapy](https://eptc.ge/addressing-superbug-resistance-phage-therapy/): International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug resistant bacterial infections.
- [Findings of Novel Phage Therapy That Saved Professor’s Life Published](https://eptc.ge/findings-novel-phage-therapy-saved-professors-life-published/): UC San Diego Health’s Robert Schooley, MD, and Randy Taplitz, MD, administer intravenous experimental phage therapy to patient Tom Patterson, four months after he contracted a multidrug-resistant bacterial infection in Egypt.
- [Bacteriophage](https://eptc.ge/could-antibiotic-resistant-superbugs-become-a-bigger-killer-than-cancer/): A bacteriophage is a type of virus that infects bacteria. In fact, the word "bacteriophage" literally means "bacteria eater," because bacteriophages destroy their host cells. All bacteriophages are composed of a nucleic acid molecule that is surrounded by a protein structure. A bacteriophage attaches itself to a susceptible bacterium and infects the host cell. Following infection, the bacteriophage hijacks the bacterium's cellular machinery to prevent it from producing bacterial components and instead forces the cell to produce viral components. Eventually, new bacteriophages assemble and burst out of the bacterium in a process called lysis. Bacteriophages occasionally remove a portion of their host cells' bacterial DNA during the infection process and then transfer this DNA into the genome of new host cells. This process is known as transduction.
- [Phage therapy in a 16 year old boy with Netherton’s Syndrome](https://eptc.ge/phage-therapy-16-year-old-boy-nethertons-syndrome/): Netherton’s Syndrome (NS) is a rare autosomal recessive disorder, characterized by a classical triad of clinical features, including congenital ichthyosiform erythroderma, trichorrhexis invaginata, and atopic diathesis coupled with frequent bacterial infections. The genetic basis for the disease has been recently identified with mutations in gene SPINK5 which is involved in the regulation of formation of skin barriers. We report on a 16-year-old male with all the typical manifestations of NS, including atopic diathesis and ongoing serious staphylococcal infections and allergy to multiple antibiotics whose family sought help at the Eliava Phage Therapy Center when all other treatment options were failing. Treatment with several antistaphylococcal bacteriophage preparations led to significant improvement within 7 days and very substantial changes in his symptoms and quality of life after treatment for 6 months, including return visits to the Eliava Phage Therapy Center after 3 and 6 months of ongoing use of phage at home.
- [Alarming rise in children’s resistance to antibiotics](https://eptc.ge/alarming-rise-childrens-resistance-antibiotics/): It is estimated that of the 7.5 lakh neonates who die in India every year, 20.8% succumb to infections like sepsis and pneumonia, among others. It is this group that needs antibiotics; overusing antibiotics could cause more resistance.Pediatrician Dr Bhupendra Avasti concurred that antibiotic resistance in Indian neonatal pediatric ICUs is a medical emergency. He said a five-year study at Surya Hospital in Santa Cruz revealed that the most common infections in NICU are klebsiella pneumoniae, acinetobacter and E coli. "Indian NICUs rarely see gram-positive organisms (which have thick cell wall).Yet, the common practice in hospitals is to start children on drugs meant to treat gram positive superbug called MRSA. This could worsen the resistance," he said.The study is perhaps the first largest pooled data on resistance in bloodstream infections in Indian children.  Source: "http://timesofindia.indiatimes.com/life-style/health-fitness/health-news/alarming-rise-in-childrens-resistance-to-antibiotics/articleshow/59093112.cms"
- [Young Edmonds boy MRSA free after unusual treatment](https://eptc.ge/young-edmonds-boy-mrsa-free-unusual-treatment/): Source: "http://komonews.com/news/healthworks/young-edmonds-boy-mrsa-free-after-unusual-treatment"
- [Superbug C. auris identified in 122 people across 7 states, CDC says](https://eptc.ge/superbug-c-auris-identified-122-people-across-7-states-cdc-says/): (CNN)The number of cases of an emerging and often multidrug-resistant fungus in the United States has grown from seven to 122 over the past nine months, according to a field report in the Morbidity and Mortality Weekly Report issued Thursday by the US Centers for Disease Control and Prevention.
- [Houston superbug may be a warning of nightmares to come](https://eptc.ge/houston-superbug-may-warning-nightmares-come/): A dangerous strain of antibiotic-resistant bacteria is far more common in Houston than anyone knew and shows signs it can spread prolifically, researchers reported Tuesday.
- [Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence](https://eptc.ge/phage-therapy-treatment-drug-resistant-bacterial-infection-aid/): In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case (Pseudomonas aeruginosa related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases (Pseudomonas aeruginosa related LRTI and Klebsiella pneumoniae related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy.
- [Phage Therapy Saves Patient from Drug-Resistant Microbes](https://eptc.ge/phage-therapy-saves-patient-drug-resistant-microbes/): Source: http://www.genengnews.com/gen-news-highlights/phage-therapy-saves-patient-from-drug-resistant-microbes/81254258
- [Phage Therapy: An Effective Alternative to Antibiotics?](https://eptc.ge/phage-therapy-an-effective-alternative-to-antibiotics/): Finding an effective alternative to antibiotics has become a critical necessity in modern medicine. As global resistance grows, phage therapy stands out as the most reliable and effective alternative to antibiotics for patients battling chronic infections. This video explains why bacteriophages are a safe, non-toxic, and highly effective alternative to antibiotics, targeting only harmful bacteria while preserving your body's natural flora. At the Eliava Center, we specialize in providing this effective alternative to antibiotics through personalized treatment protocols. If you are looking for a scientifically proven and effective alternative to antibiotics, our phage therapy solutions offer a path to recovery where traditional medicine has failed.
- [Phage therapy shown to kill drug-resistant superbug](https://eptc.ge/phage-therapy-shown-kill-drug-resistant-superbug/): Source: "http://www.finchannel.com/society/health-beauty/63838-phage-therapy-shown-to-kill-drug-resistant-superbug"

## Pages
- [sitemap](https://eptc.ge/sitemap/)
- [Landing-NL](https://eptc.ge/landing-nl/): Bacteriofagentherapiecentrum Eliava werkt ook samen met het Georgisch-Amerikaanse diagnostisch centrum.  De kliniek biedt state-of-the-art, state-of-the-art diagnostische apparatuur zoals magnetische resonantiebeeldvorming (MRI), computertomografie (CT), echografie, densitometrie en röntgenfoto`s, en gebruikt protocollen in overeenstemming met de American Radiological Association.  De kliniek zorgt voor een hoogwaardige en nauwkeurige interpretatie van de resultaten met behulp van Amerikaanse radiologen die de beelden elektronisch controleren en aanbevelingen per e-mail sturen. Biedt een complexe behandeling van ziekten van de wervelkolom, inclusief vruchtwatertherapie op het Accu-SPINA-apparaat.  Georgian American Diagnostic Center biedt gespecialiseerde behandeling op de volgende gebieden
- [Landing-DE](https://eptc.ge/landing-de/): Die Bakteriophagentherapie ist der Einsatz "guter" Viren (Bakterienviren) zur Behandlung antibiotikaresistenter oder chronischer bakterieller Infektionen. Wenn ein Patient eine bakterielle Infektion hat, wird eine entsprechende Körperflüssigkeit oder ein Abstrich kultiviert, um die Bakterien zu bestimmen, die den Körper infizieren. Nach Erhalt der Kultur werden verschiedene Phagen auf die kultivierten Bakterien aufgebracht, um zu testen, ob sie von den Phagen abgetötet werden können. Sobald ein empfindlicher Bakteriophage identifiziert ist, wird er zur Behandlung der Infektion eingesetzt
- [Landing-EN](https://eptc.ge/landing/): Since 1923, Eliava Institute has been scientifically researching and developing phages. It has created the most diverse phage collection in the world and owns the largest scientific data on bacteriophages
- [Our Partners](https://eptc.ge/our-partners/): Se soigner en Georgie Bravo Travel Lies Planje Vitalis Phage Therapy MediGroup
- [Treatments](https://eptc.ge/treatments/): The main package the EPTC offers is the local package, which means coming to our clinic in Tbilisi, Georgia, and receiving outpatient surgical and non-surgical consultations, procedures, examinations, etc.
- [Home](https://eptc.ge/): The Eliava Phage Therapy Center has specialists in the fields of Pediatrics, Internal Medicine, Urology, Gynecology and offers outpatient surgical consultations whose treatment strategies emphasize the use of bacteriophage as the cornerstone of complex medical service.
- [Specialties](https://eptc.ge/specialties/): The Eliava phage therapy center has specialists that offer outpatients surgical and nonsurgical consultations where treatment strategies emphasize the use of bacteriophage as a cornerstone of complex medical services addressing bacterial infections.
- [Eliava Consortium](https://eptc.ge/eliava-consortium/): Eliava Consortium is a joint venture of The Eliava Institute of Bacteriophages, Microbiology and Virology and Eliava Foundation, with the several spin-off companies.
- [FAQ](https://eptc.ge/faq/): What diseases can be treated with phage therapy?
- [Media](https://eptc.ge/media/): EPTCJuly 1, 2019
- [Contact](https://eptc.ge/contact/): Get in touch
- [About EPTC](https://eptc.ge/about-eptc/): We are proud to be one of the world's leading centers dedicated to phage therapy, at the forefront of groundbreaking medical advancements. As part of the renowned Eliava Institute of Bacteriophages, Microbiology, and Virology, our research facility has been actively involved in bacteriophage science and applications since its establishment in 1923. At the Eliava Phage Therapy Center, we have assembled a team of highly skilled specialists in various medical fields, including Pediatrics, Internal Medicine, Urology, and Gynecology. We also provide comprehensive outpatient surgical consultations. Our primary focus is on delivering cutting-edge medical services that prioritize using bacteriophages, harnessing their potential to effectively fight against complex health conditions.
- [Telemedicine](https://eptc.ge/telemedicine/): The Eliava Phage Therapy Center offers a Telemedicine program. This allows patients and physicians to communicate in real-time while also maintaining HIPAA, GDPR, PHIPA/PIPEDA, & HITECH compliance. Physicians can assess a patient’s medical history, perform evaluations, and more usinginteractive medicine. Online consultations are very convenient and make sense if you want to check your medical prescriptions when you don’t have a traveling possibility.

## Portfolio
- [Se soigner en Georgie](https://eptc.ge/partner/se-soigner-en-georgie/): Donec dignissim gravida posuere sagittis dolor.
- [Bravo Travel](https://eptc.ge/partner/bravo-travel/): Purus creative - dolor amet sem nibh mattis in varius egestas.
- [Lies Planje](https://eptc.ge/partner/lies-planje/): Dignissim from nulla gravida posuere sagittis creative donec vel variusdolor.
- [Vitalis Phage Therapy](https://eptc.ge/partner/vitalis-phage-therapy/): Glavrida from amet - lorem glavrida nullam porta nulla non arcu lorem.
- [MediGroup](https://eptc.ge/partner/medigroup/): Donec dignissim gravida posuere sagittis dolor.

## Team
- [Dea Nizharadze, MD](https://eptc.ge/team/dea-nizharadze/): Chief Physician
- [Lia Nadareishvili, MD](https://eptc.ge/team/lia-nadareishvili/): Internal Medicine
- [Irma Tedoradze, MD](https://eptc.ge/team/irma-tedoradze/): Ob/Gyn
- [Nana Kancheli, MD](https://eptc.ge/team/nana-kancheli/): Dermat. Endocrinologist
- [Levan Pipia, MD](https://eptc.ge/team/levan-pipia/): Urologist
- [Gogi Khvichia, MD](https://eptc.ge/team/gogi-khvichia/): ENT
- [Nino Odishelidze, MD](https://eptc.ge/team/nino-odishelidze/): Ob/Gyn
- [Lia Trapaidze, MD](https://eptc.ge/team/lia-trapaidze/): Pulmonologist
- [Mariam Dadiani](https://eptc.ge/team/mariam-dadiani/): Physician Assistant
- [Ia Qutateladze](https://eptc.ge/team/ia-qutateladze/): Nurse / Phlebotomist
- [Lana Abesadze](https://eptc.ge/team/lana-abesadze/): Patient Relations Manager
- [Keti Saralidze](https://eptc.ge/team/keti-saralidze/): Office Manager
- [Tamuna Beruashvili](https://eptc.ge/team/tamuna-beruashvili/): Administrator